Fig. 1: Flowchart of the processes for developing and validating the prognosis signature.

The first step is to construct a prognostic signature for the relapse risk of stage II CRC. The second step is to verify the prognostic signature through ROC analysis, survival analysis and multi-dimensional omics analysis.